Log in
Enquire now

List of SBIR/STTR awards granted to Integrated Biotherapeutics, Inc.

List of SBIR/STTR awards granted to Integrated Biotherapeutics, Inc.
List of SBIR/STTR awards granted to Ftl Systems
List of SBIR/STTR awards granted to LAUNCHPOINT TECHNOLOGIES, INC.
List of SBIR/STTR awards granted to Information International Associates
List of BehavioSec patents
List of Hong Kong Polytechnic University patents
where
SBIR/STTR Award Recipient
is
‌
Integrated Biotherapeutics, Inc.
Name
Description
SBIR/STTR Award Recipient
Government Agency
Government Branch
Award Type
Contract Number (US Government)
Award Phase
Award Amount (USD)
Date Awarded
Official Website
‌
Integrated Biotherapeutics, Inc. STTR Phase II Award, July 2019

A STTR Phase II contract was awarded to Integrated Biotherapeutics, Inc. in July, 2019 for $999,997.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

‌
Integrated Biotherapeutics, Inc.
National Institutes of Health
National Institutes of Health
STTR
2R42AI122666-03
Phase II
999,997
July 5, 2019
sbir.gov/node/1684723
‌
Integrated Biotherapeutics, Inc. STTR Phase I Award, July 2019

A STTR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in July, 2019 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

‌
Integrated Biotherapeutics, Inc.
National Institutes of Health
National Institutes of Health
STTR
1R41AI147929-01
Phase I
300,000
July 12, 2019
sbir.gov/node/1683821
‌
Integrated Biotherapeutics, Inc. SBIR Phase I Award, April 2019

A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in April, 2019 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

‌
Integrated Biotherapeutics, Inc.
National Institutes of Health
National Institutes of Health
SBIR
1R43AI145480-01
Phase I
300,000
April 1, 2019
sbir.gov/node/1680989
‌
Integrated Biotherapeutics, Inc. SBIR Phase I Award, April 2019

A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in April, 2019 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

‌
Integrated Biotherapeutics, Inc.
National Institutes of Health
National Institutes of Health
SBIR
1R43AI136143-01A1
Phase I
300,000
April 1, 2019
sbir.gov/node/1689985
‌
Integrated Biotherapeutics, Inc. SBIR Phase II Award, April 2021

A SBIR Phase II contract was awarded to Integrated Biotherapeutics, Inc. in April, 2021 for $804,193.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

‌
Integrated Biotherapeutics, Inc.
National Institutes of Health
National Institutes of Health
SBIR
4R44AI140932-02
Phase II
804,193
April 8, 2021
sbir.gov/node/2192415
‌
Integrated Biotherapeutics, Inc. SBIR Phase I Award, March 2019

A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in March, 2019 for $290,038.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

‌
Integrated Biotherapeutics, Inc.
National Institutes of Health
National Institutes of Health
SBIR
1R44AI140932-01A1
Phase I
290,038
March 14, 2019
sbir.gov/node/1689829
‌
Integrated Biotherapeutics, Inc. SBIR Phase II Award, May 2021

A SBIR Phase II contract was awarded to Integrated Biotherapeutics, Inc. in May, 2021 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

‌
Integrated Biotherapeutics, Inc.
National Institutes of Health
National Institutes of Health
SBIR
1R44AI155309-01A1
Phase II
1,000,000
May 12, 2021
sbir.gov/node/2187373
‌
Integrated Biotherapeutics, Inc. SBIR Phase I Award, January 2018

A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in January, 2018 for $601,655.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

‌
Integrated Biotherapeutics, Inc.
National Institutes of Health
National Institutes of Health
SBIR
1R43AI136229-01
Phase I
601,655
January 26, 2018
sbir.gov/node/1565025
‌
Integrated Biotherapeutics, Inc. STTR Phase I Award, July 2020

A STTR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in July, 2020 for $299,939.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

‌
Integrated Biotherapeutics, Inc.
National Institutes of Health
National Institutes of Health
STTR
1R41AI152745-01A1
Phase I
299,939
July 6, 2020
sbir.gov/node/1916155
‌
Integrated Biotherapeutics, Inc. SBIR Phase I Award, June 2014

A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in June, 2014 for $599,996.0 USD from the U.S. Department of Health & Human Services.

‌
Integrated Biotherapeutics, Inc.
SBIR
1R43AI106162-01A1
Phase I
599,996
June 15, 2014
sbir.gov/node/1043721
‌
Integrated Biotherapeutics, Inc. SBIR Phase I Award, February 2015

A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in February, 2015 for $230,063.0 USD from the U.S. Department of Health & Human Services.

‌
Integrated Biotherapeutics, Inc.
SBIR
1R43AI113959-01A1
Phase I
230,063
February 1, 2015
sbir.gov/node/1029557
‌
Integrated Biotherapeutics, Inc. SBIR Phase II Award, January 2009

A SBIR Phase II contract was awarded to Integrated Biotherapeutics, Inc. in January, 2009 for $1,159,390.0 USD from the U.S. Department of Defense.

‌
Integrated Biotherapeutics, Inc.
U.S. Department of Defense
U.S. Department of Defense
SBIR
W81XWH-08-C-0004
Phase II
1,159,390
January 15, 2009
sbir.gov/content/therapeutic-human-hyperimmune-polyclonal-antibodies-against-staphylococcal-enterotoxin-b-2
‌
Integrated Biotherapeutics, Inc. STTR Phase II Award, July 2017

A STTR Phase II contract was awarded to Integrated Biotherapeutics, Inc. in July, 2017 for $1,861,259.0 USD from the U.S. Department of Health & Human Services.

‌
Integrated Biotherapeutics, Inc.
STTR
2R42AI122403-02
Phase II
1,861,259
July 1, 2017
sbir.gov/node/1304699
‌
Integrated Biotherapeutics, Inc. STTR Phase I Award, February 2017

A STTR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in February, 2017 for $594,931.0 USD from the U.S. Department of Health & Human Services.

‌
Integrated Biotherapeutics, Inc.
STTR
1R41AI122666-01A1
Phase I
594,931
February 15, 2017
sbir.gov/node/1247991
‌
Integrated Biotherapeutics, Inc. SBIR Phase I Award, July 2016

A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in July, 2016 for $284,365.0 USD from the U.S. Department of Health & Human Services.

‌
Integrated Biotherapeutics, Inc.
SBIR
1R43AI124765-01A1
Phase I
284,365
July 1, 2016
sbir.gov/node/1163145
‌
Integrated Biotherapeutics, Inc. STTR Phase I Award, July 2016

A STTR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in July, 2016 for $229,991.0 USD from the U.S. Department of Health & Human Services.

‌
Integrated Biotherapeutics, Inc.
STTR
1R41AI122403-01
Phase I
229,991
July 5, 2016
sbir.gov/node/1195199
‌
Integrated Biotherapeutics, Inc. SBIR Phase I Award, February 2017

A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in February, 2017 for $438,765.0 USD from the U.S. Department of Health & Human Services.

‌
Integrated Biotherapeutics, Inc.
SBIR
1R43AI129218-01
Phase I
438,765
February 10, 2017
sbir.gov/node/1246521
‌
Integrated Biotherapeutics, Inc. SBIR Phase I Award, October 2007

A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. in October, 2007 for $109,774.0 USD from the U.S. Department of Defense.

‌
Integrated Biotherapeutics, Inc.
U.S. Department of Defense
U.S. Department of Defense
SBIR
W81XWH-08-C-0004
Phase I
109,774
October 19, 2007
sbir.gov/content/therapeutic-human-hyperimmune-polyclonal-antibodies-against-staphylococcal-enterotoxin-b-0
‌
Integrated Biotherapeutics, Inc. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. for $600,000.0 USD from the U.S. Department of Health & Human Services.

‌
Integrated Biotherapeutics, Inc.
SBIR
1R43AI094829-01
Phase I
600,000
sbir.gov/content/development-novel-second-generation-pan-filovirus-subunit-vaccine
‌
Integrated Biotherapeutics, Inc. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. for $593,316.0 USD from the U.S. Department of Health & Human Services.

‌
Integrated Biotherapeutics, Inc.
SBIR
1R43AI100414-01A1
Phase I
593,316
sbir.gov/node/399764
‌
Integrated Biotherapeutics, Inc. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. for $600,000.0 USD from the U.S. Department of Health & Human Services.

‌
Integrated Biotherapeutics, Inc.
SBIR
1R43AI085665-01
Phase I
600,000
sbir.gov/node/6045
‌
Integrated Biotherapeutics, Inc. STTR Phase I Award,

A STTR Phase I contract was awarded to Integrated Biotherapeutics, Inc. for $600,000.0 USD from the U.S. Department of Health & Human Services.

‌
Integrated Biotherapeutics, Inc.
STTR
1R41AI108024-01
Phase I
600,000
sbir.gov/node/677023
‌
Integrated Biotherapeutics, Inc. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. for $590,778.0 USD from the U.S. Department of Health & Human Services.

‌
Integrated Biotherapeutics, Inc.
SBIR
1R43AI098232-01
Phase I
590,778
sbir.gov/node/399694
‌
Integrated Biotherapeutics, Inc. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Integrated Biotherapeutics, Inc. for $550,414.0 USD from the U.S. Department of Health & Human Services.

‌
Integrated Biotherapeutics, Inc.
SBIR
1R43AI098178-01A1
Phase I
550,414
sbir.gov/node/399672
24 results
0 selected
24 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us